Activity

A masked randomised control design compared the effectiveness of precision ophthalmic tints in improving the recognition of emotion in Autism Spectrum Disorders (ASD). Fourteen children aged 10-14 with ASD and 14 control children matched on verbal and non-verbal IQ, wore spectacles with coloured lenses to complete two tasks that involved the observation of coloured video sequences in which social interactions were depicted. On one occasion (randomly first or second) the coloured lenses provided light of a colour that the child had one month previously selected as optimal for the clarity of text. On the other occasion the lenses differed in CIE UCS chromaticity by 0.077. Performance in the ASD group was superior in both social interaction tasks with the lenses that provided the optimal colour of light. PURPOSE To compare the biomechanical characteristics of the interconnected knotless anchor fixation with the double knotless anchor and interference screw fixation in the suprapectoral biceps tenodesis. METHODS 24 fresh-frozen human cadaveric shoulders (mean age, 67.3 ± 6 years) were utilized for the study. All the specimens were randomly divided into three experimental biceps tenodesis groups (n = 8) interconnected knotless anchor (IKA), double knotless anchor (DKA), and interference screw (IS). After tenodesis, each specimen was preloaded at 5 N for 2 min, followed by a cyclic loading test from 5 to 70 N for 500 load cycles. Finally, a destructive axial load to failure test (1 mm/s) was performed. All the values, including ultimate failure load, stiffness, cyclic displacement, and mode of failure were evaluated. RESULTS The interconnected knotless anchor provided the highest construct stiffness (38.9±7.7 N/mm) and ultimate failure load (288.3±47.6 N), the results for which were statistically better than the corresponding results in the interference screw and double knotless anchor groups. In terms of cyclic displacement, there were no statistical differences among the three fixation constructs. The most common failure mode was biceps tendon tearing in interference screw group (7/8) and interconnected knotless anchors group (8/8). In the contrast, suture slippage accounted for the most common failure mode in double knotless anchors. CONCLUSIONS In suprapectoral bicep tenodesis, interconnected knotless anchor (IKA) fixation appears to offer improved construct stiffness and ultimate failure load while maintaining comparable suture slippage as compared to interference screw (IS) fixation or double knotless anchor (DKA) fixation in the current biomechanical study. CLINICAL RELEVANCE The interconnected knotless anchors (IKA) fixation compares favorably with other techniques and could be an alternative clinical option for suprapectoral biceps tenodesis. PURPOSE We aimed to establish the characteristics of synovium-derived mesenchymal stem cells (MSCs) from the hip joints of patients with femoroacetabular impingement syndrome (FAIS) and osteoarthritis (OA), particularly their proliferation and differentiation potentials. We further investigated their functional differences. METHODS Synovium samples were harvested from 21 patients with FAIS who underwent hip arthroscopic surgery and from 14 patients with OA who underwent total hip arthroplasty. The MSC number, colony forming units, cell viability, and differentiation potential were compared. Real-time PCR assessed the differentiation potential into adipose, bone, and cartilage tissues. P7C3 mouse RESULTS The number of colonies at a density of 104 at passage 0 from OA synovium was significantly higher than that from FAIS synovium (p less then 0.01). However, their proliferation and viability were significantly lower than those of FAIS synovium cells (p = 0.0495). The expression of lipoprotein lipase mRNA in OA synovium cells was higher than that in FAIS synovium cells (p less then 0.01). Meanwhile, the fraction of colonies positive for von Kossa and alkaline phosphatase staining, as well as the level of bone gamma-carboxyglutamate protein expression in OA synovium cells, were higher than those in FAIS synovium cells (p less then 0.01). In chondrogenic pellet culture experiments, the expression of COL10A1 mRNA was lower in OA synovium than in FAIS synovium (p less then 0.01). CONCLUSION Synovial MSCs from OA patients had greater colony numbers but less viability and proliferative potential. They also showed greater osteogenic and adipogenic potentials, whereas those from FAIS patients showed greater chondrogenic potential. The versatility and nanoscale size have helped nanoparticles (NP) improve the efficacy of conventional cancer immunotherapy and opened up exciting approaches to combat cancer. This review first outlines the tumor immune evasion and the defensive tumor microenvironment (TME) that hinders the activity of host immune system against tumor. Then, a detailed description on how the NP based strategies have helped improve the efficacy of conventional cancer vaccines and overcome the obstacles led by TME. Sustained and controlled drug delivery, enhanced cross presentation by immune cells, co-encapsulation of adjuvants, inhibition of immune checkpoints and intrinsic adjuvant like properties have aided NPs to improve the therapeutic efficacy of cancer vaccines. Also, NPs have been efficient modulators of TME. In this context, NPs facilitate better penetration of the chemotherapeutic drug by dissolution of the inhibitory meshwork formed by tumor associated cells, blood vessels, soluble mediators and extra cellular matrix in TME. NPs have shown to achieve this by suppression, modulation, or reprogramming of the immune cells and other mediators localised in TME. In this review, we summarize applications of NPs used to enhance the efficacy of cancer vaccines and modulate the TME to improve cancer immunotherapy. Finally, the hurdles faced in commercialization and translation to clinic have been discussed and intriguingly, NPs owe great potential to emerge as clinical formulations for cancer immunotherapy in near future. In the recent years the rapid scientific innovation in the evaluation of the individual’s genome have allowed the identification of variants associated with the onset, treatment and prognosis of various pathologies including cancer, and with a potential impact in the assessment of therapy responses. Despite the analysis and interpretation of genomic information is considered incomplete, in many cases the identification of specific genomic profile has allowed the stratification of subgroups of patients characterized by a better response to drug therapies. Individual genome analysis has changed profoundly the diagnostic and therapeutic approach of breast cancer in the last 15 years by identifying selective molecular lesions that drive the development of neoplasms, showing that each tumor has its own genomic signature, with some specific features and some features common to several sub-types. Several personalized therapies have been (and still are being) developed showing a remarkable efficacy in the treatment of breast cancer.